James Hakim

3.4k total citations
19 papers, 626 citations indexed

About

James Hakim is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, James Hakim has authored 19 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 7 papers in Virology and 4 papers in Epidemiology. Recurrent topics in James Hakim's work include HIV/AIDS drug development and treatment (12 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (7 papers). James Hakim is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (7 papers). James Hakim collaborates with scholars based in Zimbabwe, United Kingdom and Uganda. James Hakim's co-authors include Cissy Kityo, Valerie J. Robertson, Innocent T. Gangaidzo, Peter R. Mason, Robert S. Heyderman, Jens Mielke, Charles F. Gilks, Paula Munderi, Diana M. Gibb and Andrew Reid and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

James Hakim

19 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Hakim Zimbabwe 12 479 258 162 160 42 19 626
T. May France 12 238 0.5× 211 0.8× 73 0.5× 122 0.8× 19 0.5× 30 459
Pongsakdi Chaisilwattana Thailand 9 204 0.4× 139 0.5× 88 0.5× 111 0.7× 30 0.7× 25 449
Godspower Akpomiemie South Africa 12 648 1.4× 210 0.8× 426 2.6× 337 2.1× 18 0.4× 24 881
Alberto Martín-Hidalgo Spain 8 133 0.3× 132 0.5× 115 0.7× 53 0.3× 32 0.8× 13 400
Corinne Merle De Boever France 8 321 0.7× 188 0.7× 184 1.1× 177 1.1× 21 0.5× 12 515
BG Gazzard United Kingdom 9 201 0.4× 64 0.2× 84 0.5× 112 0.7× 37 0.9× 20 351
Michel Garré France 9 216 0.5× 169 0.7× 59 0.4× 108 0.7× 52 1.2× 18 472
José Ramón Santos Spain 17 612 1.3× 177 0.7× 192 1.2× 487 3.0× 15 0.4× 40 796
Jean–Baptiste Guiard–Schmid France 12 203 0.4× 159 0.6× 68 0.4× 69 0.4× 22 0.5× 26 392
Marzia Franzetti Italy 12 247 0.5× 177 0.7× 159 1.0× 95 0.6× 80 1.9× 21 458

Countries citing papers authored by James Hakim

Since Specialization
Citations

This map shows the geographic impact of James Hakim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Hakim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Hakim more than expected).

Fields of papers citing papers by James Hakim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Hakim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Hakim. The network helps show where James Hakim may publish in the future.

Co-authorship network of co-authors of James Hakim

This figure shows the co-authorship network connecting the top 25 collaborators of James Hakim. A scholar is included among the top collaborators of James Hakim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Hakim. James Hakim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Paton, Nicholas I., Joseph Musaazi, Cissy Kityo, et al.. (2021). Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. New England Journal of Medicine. 385(4). 330–341. 91 indexed citations
2.
Moore, Cecilia L., Hilda Mujuru, Shafic Makumbi, et al.. (2020). Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial. The Lancet HIV. 7(8). e533–e544. 21 indexed citations
3.
4.
Dolling, David, Ruth Goodall, M. Chirara, et al.. (2017). The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data. BMC Infectious Diseases. 17(1). 160–160. 3 indexed citations
5.
Mukherjee, Pranab K., Huichao Chen, Lauren L. Patton, et al.. (2016). Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. AIDS. 31(1). 81–88. 13 indexed citations
6.
Mujuru, Hilda, Marshall Munjoma, Willard Tinago, et al.. (2015). Hematological and Biochemical Laboratory Reference Intervals for Zimbabwean Adolescents. Clinical Laboratory. 61(01+02/2015). 101–11. 5 indexed citations
7.
Smeaton, Laura, Thomas Campbell, Cynthia Riviere, et al.. (2014). Renal and Metabolic Toxicities Following Initiation of HIV-1 Treatment Regimen in a Diverse, Multinational Setting: A Focused Safety Analysis of ACTG PEARLS (A5175). HIV Clinical Trials. 15(6). 246–260. 9 indexed citations
8.
Havers, Fiona P., Laura Smeaton, Nikhil Gupte, et al.. (2014). 25-Hydroxyvitamin D Insufficiency and Deficiency is Associated With HIV Disease Progression and Virological Failure Post-Antiretroviral Therapy Initiation in Diverse Multinational Settings. The Journal of Infectious Diseases. 210(2). 244–253. 41 indexed citations
9.
Stöhr, Wolfgang, Andrew Reid, A. Sarah Walker, et al.. (2011). Glomerular Dysfunction and Associated Risk Factors over 4–5 Years following Antiretroviral Therapy Initiation in Africa. Antiviral Therapy. 16(7). 1011–1020. 30 indexed citations
10.
Lyagoba, Fred, David Dunn, Deenan Pillay, et al.. (2010). Evolution of Drug Resistance During 48 Weeks of Zidovudine/Lamivudine/Tenofovir in the Absence of Real-Time Viral Load Monitoring. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(2). 277–283. 21 indexed citations
11.
Pillay, Deenan, Ruth Goodall, Charles F. Gilks, et al.. (2010). Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa. Journal of the International AIDS Society. 13. O20–O20. 7 indexed citations
12.
Lara, A. Medina, Jesse Kigozi, Jovita Amurwon, et al.. (2009). Cost Effectiveness Analysis of Routine Laboratory or Clinically Driven Strategies for Monitoring Anti-Retroviral Therapy in Uganda and Zimbabwe (DART Trial). 15 indexed citations
13.
Reid, Andrew, Wolfgang Stöhr, A Sarah Walker, et al.. (2008). Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV‐Infected Adults in Africa Initiating Antiretroviral Therapy. Clinical Infectious Diseases. 46(8). 1271–1281. 127 indexed citations
14.
Hakim, James, et al.. (2008). Distinguished Tame Supercuspidal Representations. HighWire Press Open Archive. 22 indexed citations
15.
Reid, Andrew, Wolfgang Stöhr, A Sarah Walker, et al.. (2008). Glomerular dysfunction and associated risk factors through four years following initiation of ART in adults with HIV Infection in Africa in the DART trial. 1. 2 indexed citations
16.
Corbett, Elizabeth L., Ethel Dauya, Yin Bun Cheung, et al.. (2007). Nursing and Community Rates of Mycobacterium tuberculosis Infection among Students in Harare, Zimbabwe. Clinical Infectious Diseases. 44(3). 317–323. 29 indexed citations
17.
Pillay, Deenan, C. Kityo, Val J. Robertson, et al.. (2007). Emergence and evolution of drug resistance in the absence of viral load monitoring during 48 weeks of Combivir/Tenofovir within the DART Trial.. 8 indexed citations
18.
Hakim, James, Innocent T. Gangaidzo, Robert S. Heyderman, et al.. (2000). Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS. 14(10). 1401–1407. 167 indexed citations
19.
Stone, Stephen, et al.. (1988). Cryptococcal meningitis presenting as uveitis.. British Journal of Ophthalmology. 72(3). 167–170. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. May Breakdown of academic impact, for papers by Pongsakdi Chaisilwattana Breakdown of academic impact, for papers by Godspower Akpomiemie Breakdown of academic impact, for papers by Alberto Martín-Hidalgo Breakdown of academic impact, for papers by Corinne Merle De Boever Breakdown of academic impact, for papers by BG Gazzard Breakdown of academic impact, for papers by Michel Garré Breakdown of academic impact, for papers by José Ramón Santos Breakdown of academic impact, for papers by Jean–Baptiste Guiard–Schmid Breakdown of academic impact, for papers by Marzia Franzetti
Rankless by CCL
2026